Gland Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

1,174.83

1,097.86

1,010.67

884.07

785.42

Operating profit

432.83

369.49

347.10

259.36

169.15

Interest

4.53

0.80

0.91

1.60

2.18

Gross profit

475.25

412.08

387.30

292.97

205.91

EPS (Rs)

19.51

16.81

15.64

11.39

4.81

Other income

46.96

43.39

41.11

35.21

38.94

Stock adjustment

26.97

103.70

-22.74

-20.49

-76.69

Raw material

482.88

378.43

456.63

391.80

438.38

Power and fuel

28.91

28.62

-

-

29.51

Employee expenses

107.87

99.29

99.88

102.91

100.02

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

95.38

118.34

129.80

150.49

125.05

Provisions made

-

-

-

-

-

Depreciation

42.56

40.33

40.24

38.98

37.54

Taxation

111.28

94.95

89.54

66.41

32.70

Net profit / loss

321.41

276.81

257.53

187.58

79.21

Extra ordinary item

-

-

-

-

-56.46

Prior year adjustments

-

-

-

-

-

Equity capital

16.47

16.47

16.47

16.47

16.47

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

36.84

33.66

34.34

29.34

21.54

GPM (%)

38.90

36.11

36.82

31.87

24.98

NPM (%)

26.31

24.25

24.48

20.41

9.61